The Little-Known History of the Forced Sterilization of Native American Women
By Erin Blakemore,
JSTOR Daily
| 08. 25. 2016
Two fifteen-year-old Native American women went into the hospital for tonsillectomies and came out with tubal ligations. Another Native American woman requested a “womb transplant,” only to reveal that she had been told that was an option after her uterus had been removed against her will. Cheyenne women had their Fallopian tubes severed, sometimes after being told that they could be “untied” again.
For many, America’s history of brutal experimentation on people of color is perhaps best summed up by the Tuskegee Experiment, in which doctors let African-American men suffer from syphilis over a period of 40 years. But another medical outrage is less well-known. Jane Lawrence documents the forced sterilization of thousands of Native American women by the Indian Health Service in the 1960s and 1970s—procedures thought to have been performed on one out of every four Native American women at the time, against their knowledge or consent.
Both the IHS and its dark history of forced sterilization were the result of longstanding, often ham-fisted attempts to address American Indians’ health care needs, writes Lawrence...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...